Eisenmenger Quality Enhancement Research Initiative

CompletedOBSERVATIONAL
Enrollment

193

Participants

Timeline

Start Date

July 1, 2012

Primary Completion Date

April 17, 2018

Study Completion Date

April 17, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
OTHER

Subjects with diagnosis of Eisenmenger Syndrome

"1. Antibiotic recommendation for SBE prophylaxis and influenza vaccine~2. Contraception counseling, and recommendations regarding avoidance of pregnancy~3. Documentation and prescription of the specific medications:~ 1. Oxygen~ 2. Diuretic~ 3. ASA, Anticoagulant~ 4. CCB, BB, ACEI, ARB~ 5. Iron Supplementation~ 6. Allopurinol~ 7. PAH specific therapy"

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Canadian Heart Research Centre

OTHER

lead

Actelion

INDUSTRY

NCT01623492 - Eisenmenger Quality Enhancement Research Initiative | Biotech Hunter | Biotech Hunter